Drugs / BMA
last change Jul 2020 re-read 3 minutes ago

BMA

Developed for
osteoarthritis, knee
Investigated by
Hospital for Special Surgery, New York

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT03130335 Apr 2017 → Aug 2019 osteoarthritis, knee Hospital for Special Surgery, New York Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as BMA ClinicalTrials.gov intervention name — accepted as the source's own label NCT03130335 ↗
Route Other “then injected intra-articularly under fluoroscopic and/or ultrasound guidance.” PMID 32500620 ↗ Jul 2020